Upcoming Discipline Hearings

Hearing Dates: January 26, 2022,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that David Morkos, as dispensing pharmacist and/or Designated Manager at Woodgreen Pharmacy at 101 – 69 Queen Street East in Toronto, Ontario (the Pharmacy), and/or as a shareholder of the corporation that owned the Pharmacy, in the period from about March 2019 to September 2020, while engaged in the practice of pharmacy in the Province of Ontario, committed professional misconduct in that he:

• Failed to keep records as required by the Medication Procurement and Inventory Management Policy with respect to the inventory of narcotics and controlled drugs, including with respect to expired and/or unserviceable controlled substances;
• Failed to maintain the security of narcotics and other controlled drugs, including expired and/or unserviceable substances;
• Failed to maintain accurate records of purchases, sales and remaining inventory for narcotics and other controlled drugs;
• Failed to complete inventory reconciliations for narcotics and other controlled drugs at least once every six months, and/or failed to retain complete records of such inventory reconciliations, in 2018, 2019 and/or 2020; and/or
• Failed to make timely reports of losses of narcotics and other controlled drugs to Health Canada with respect to reconciliations conducted in 2018, 2019, and/or 2020.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required with respect to his patients or practice;
• Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, including:
  • the Narcotic Control Regulations, sections 40, 42, and/or 43 under the Controlled Drugs and Substances Act, S.C. 1996, c 19, and/or
  • the Food and Drug Regulations, sections G.03.010, G.03.012, and/or G.03.013 under the Food and Drug Act, R.S.C. 1985 c.F-27, and/or
  • ss. 72 and 75 of the Benzodiazepines and Other Targeted Substances Regulation;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: January 31, 2022,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Robert Awad, while engaged in the practice of pharmacy as dispensing pharmacist and/or a director and/or shareholder of the corporation that owned and/or operated Aim Drug Mart in London, Ontario, committed professional misconduct in that:

• At various times between about January 1, 2015 and June 10, 2020, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for drugs and/or products that were not dispensed, and in particular, with respect to Rebif 132mcg Multi-Dose;
• At various times between about October 20, 2017 to February 11, 2020, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for drugs and/or products that were not dispensed, and in particular, with respect to intra-nasal Naloxone Kit (2), DIN 93877256;
• At various times between about January 1, 2015 and December 31, 2017, he cancelled (or permitted, consented to or approved, expressly or impliedly, the cancellation of) prescriptions that had been billed to the Ontario Drug Benefit program and that required a manual submission to ensure the reversal of the charge, without completing the manual submission, or ensuring that it was done, and therefore without ensuring the reversal of the charge.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Falsified a record relating to his practice and/or to a person’s health record;
• Submitted an account or charge for services or products that he knew or ought to know was false or misleading;
• Charged a fee that was excessive in relation to the service or product provided;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: February 11, 2022,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Anhal Yacob, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at College Centre Pharmacy located at 528 College Street in Toronto, Ontario (the Pharmacy), committed professional misconduct in that he:

1. Submitted false or unsubstantiated claims to [Insurance Provider]:
   1. between approximately December 1, 2017 and January 31, 2019 for one or more of certain identified products; and/or
   2. for one or more of certain identified prescriptions that were not actually dispensed to patients;
2. Falsified records between approximately December 1, 2017 and January 31, 2019 in respect of one of more of certain identified products and/or in respect of one or more of certain identified prescriptions.

In particular, it is alleged that he:

• Failed to maintain the standards of practice of the profession;
• Falsified records relating to his practice;
• Signed or issued, in his professional capacity, a document he knew or ought to have known contained a false or misleading statement;
• Submitted an account(s) or charge(s) for services that he knew and/or ought to have known were false or misleading;
• Failed to keep records as required respecting his patients or practice;
• Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular:
  • sections 155, 163, and 166 of the Drug and Pharmacies Regulation Act; and/or
  • sections 18, 19, and 20 of Ontario Regulation 264/16;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: February 15, 2022,

Summary of Allegations

Following a hearing on September 28, 2021, a Panel of the Discipline Committee made findings of professional misconduct against Sameh Sadek in a decision dated November 3, 2021, in that:

• He failed to report to the Registrar the details of being charged on or about February 22, 2017 with the offence of refusing to comply with a demand for a breath sample contrary to s. 254(5) of the Criminal Code of Canada;
• He failed to report to the Registrar the details of being charged on or about March 27, 2018 with the offence of assaulting a peace officer contrary to s. 270(1)(a) of the Criminal Code of Canada;
• On or about March 8, 2018, he declared to the College as part of his annual renewal process that he was not currently charged with a criminal offence or any other offence in Ontario or any other jurisdiction, when at that time he was charged with the offence of refusing to comply with a demand for a breath sample contrary to s. 254(5) of the Criminal Code of Canada;
• Between about June 1, 2017 and February 20, 2018, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) claims, charges and/or accounts for drugs that were not dispensed, and/or that were for invalid prescriptions, with respect to certain identified drugs;
• On or about April 27, 2018 and in the period following that date, he closed the Pharmacy without complying with the requirements for closing a Pharmacy, and in particular:
  • he failed to remove all signs and symbols relating to the practice of pharmacy from within and outside the premises;
  • he failed to remove and dispose of all drugs according to law;
  • he failed to submit to the Registrar a Pharmacy Closing Statement;
  • he failed to deliver prescription records;
  • he failed to ensure the Pharmacy’s records were maintained in a secure manner and for the required period of time;
• On or about June 13, 2018, July 4, 2018, and July 19, 2018, he failed to reply within a reasonable time to requests from the College relating to the closure of the Pharmacy.

In particular, the Panel found that he:

• Contravened a term, condition or limitation on his certificate of registration;
• Failed to maintain a standard of practice of the profession;
• Falsified a record relating to his practice or a person’s health record;
• Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
• Submitted an account or charge for services or products that he knew or ought to have known contained a false or misleading statement;
• Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotic Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those acts, and in particular:
  • s. 141 and s. 157(2) of the Drug and Pharmacies Regulation Act, RSO 1990, c. H.4;
  • ss. 20(2) and 21 of O. Reg. 264/16 made under the Drug and Pharmacies Regulation Act, RSO 1990, c. H.4;
• Failed to reply within a reasonable time to a written or electronic inquiry or request from the College;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable and unprofessional.

Submissions with respect to the Order to be imposed will be heard on February 15, 2022.

Hearing Dates: February 17, 2022,

Summary of Allegations

Following a hearing held on November 5 and 6, 2018; April 25, 26, 29 and 30, 2019; May 1, 2019; June 18 and 19, 2019; July 10, and 22, 2019; October 23, 2019; November 8 and 11, 2019; and December 2 and 3, 2019, a Panel of the Discipline Committee made findings of professional misconduct against Sohail Aslam, in a decision dated November 18, 2020, in that he:

1. Harassed and/or sexually harassed [Name], an employee of the Pharmacy, including by;
   1. On or about [date], in his office in the Pharmacy:
      1. Attempting, repeatedly, to reach in to her shirt and her pants;
      2. Placing her hand on his groin area;
   2. Engaging in other unwelcome advances from time to time;
2. Failed to provide to the Registrar the details of charges against him under the Criminal Code of Canada, as set out in an information sworn on or about August 13, 2015, namely charges relating to the offence of sexual assault, within 30 days of those charges having arisen, as required by the By-Laws of the Ontario College of Pharmacists.

In particular, the Panel found that he:

1. Contravened a term, condition or limitation imposed on his certificate of registration;
2. Failed to maintain the standards of the profession;
3. Engaged in conduct relevant to the practice of pharmacy that, having regard to all of the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable and unprofessional.

Submissions with respect to the Order to be imposed were heard on September 24, 2021, and December 1, 2021.

Further submissions in this matter will be heard on February 17, 2022.

Hearing Dates: May 9, 2022, May 10, 2022,

Summary of Allegations

Following a hearing held on February 2 and 4, 2021, a Panel of the Discipline Committee made findings of professional misconduct against Guo Ma with respect to two referrals from the Inquiries, Complaints and Reports Committee, as follows.

Referral 1

The Panel found that Mr. Ma, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Pharm Can Drug Mart (the “Pharmacy”) in Ottawa, committed professional misconduct in that he:

• Dispensed monitored drugs without acting on Narcotic Monitoring System alerts for one or more of certain identified prescriptions;
• Dispensed monitored drugs without documenting the actions taken, and/or the reason(s) for not taking any action, in response to Narcotic Monitoring System alerts for one or more of certain identified prescriptions; and/or,
• Dispensed one or more of certain identified prescriptions without labelling the container in which the drug(s) was dispensed.

In particular, the Panel found that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients and/or practice;
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular:
  • Sections 156 and 166 of the Drug and Pharmacies Regulation Act, section 20(1) of Ontario Regulation 264/16, and/or
  • Section 54 of Ontario Regulation 58/11;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and unprofessional

Referral 2

The Panel found that Mr. Ma, from in or about March 2015 to in or about November 2017, while engaged in the practice of pharmacy as director, shareholder, owner, designated manager, and/or dispensing pharmacist at Pharm Can Drug Mart (the “Pharmacy”) in Ottawa, Ontario, committed professional misconduct in that he:

• Dispensed and/or billed for drugs and/or products without a prescription authorized by a prescriber for one or more of certain identified drugs and/or products;
• Submitted an account or charge for services that he knew was false or misleading with respect to:
  1. one or more of certain identified drugs and/or products; and/or,
  2. one or more of certain identified claims to the Ontario Drug Benefit Program; and/or,
• Falsified a record relating to his practice with respect to:
  1. one or more of certain identified drugs and/or products; and/or,
  2. one or more of certain identified claims to the Ontario Drug Benefit Program; and/or,
• Signed or issued, in his professional capacity, a document he knew contained a false and misleading statement with respect to:
  1. one or more of certain identified drugs and/or products; and/or,
  2. one or more of certain identified claims to the Ontario Drug Benefit Program; and/or,
• Failed to keep records as required respecting his patients with respect to:
  1. one or more of certain identified drugs and/or products; and/or,
  2. one or more of certain identified claims to the Ontario Drug Benefit Program.

In particular, the Panel found that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients;
• Falsified a record relating to his practice;
• Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement;
• Submitted an account or charge for services or products that he knew and/or ought to have known was false or misleading;
• Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular:
  • sections 155, 156, 163, and 166 of the Drug and Pharmacies Regulation Act, as amended;
  • section 20(1) of Ontario Regulation 264/16, as amended;
  • sections 40 and 54(1) of Ontario Regulation 58/11;
  • sections 5, 6, 15(1), 17(2), and/or 23(1) of the Ontario Drug Benefit Act, as amended; and/or
  • sections 18, 19, 25, 27, and/or 29(1) of Ontario Regulation 201/96, as amended;
• Contravened a federal, provincial or territorial law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, with respect to the distribution, purchase, sale, dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, whose purpose is to protect or promote the public health, and/or that is otherwise relevant to his suitability to practise, and in particular:
  • sections 155, 156, 163, and 166 of the Drug and Pharmacies Regulation Act, as amended;
  • section 20(1) of Ontario Regulation 264/16, as amended;
  • sections 40 and 54(1) of Ontario Regulation 58/11, as amended;
  • sections 5, 6, 15(1), 17(2), and/or 23(1) of the Ontario Drug Benefit Act, as amended; and/or
  • sections 18, 19, 25, 27, and/or 29(1) of Ontario Regulation 201/96, as amended;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and unprofessional.

Submissions with respect to Order were heard on February 11, 2021.

Further submissions will be heard on May 9 and 10, 2022.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Rami Abdelmalek, while engaged in the practice of pharmacy as owner, director, shareholder, and/or dispensing pharmacist at Westboro Pharmasave in Ottawa, Ontario, committed professional misconduct in that he:

• Submitted (or permitted, consented to, or approved, expressly or by implication, the submissions of) claims with excessive markups for one or more of certain identified drugs and/or products from in or about November 1, 2016 to in or about April 30, 2018;
• Submitted (or permitted, consented to, or approved, expressly or by implication, the submissions of) claims to multiple plans where one or more of those plans was not obligated to pay the claim (or the full amount of the claim) for one or more of certain identified drugs and/or products from in or about November 1, 2016 to in or about April 30, 2018; and/or
• Submitted (or permitted, consented to or approved, expressly or by implication, the submissions of) claims for dispensing fees for compliance packages at more frequent intervals than the compliance packages were being dispensed for one or more patients from in or about May 1, 2018 to in or about April 24, 2019.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients and/or practice;
• Falsified a record relating to his practice and/or a person’s health record;
• Signed and/or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false and/or misleading;
• Submitted an account and/or charge for services and/or products that he knew and/or ought to have known was false and/or misleading;
• Charged (or permitted, consented to, or approved, expressly or by implication, charges for) a fee and/or amount that was excessive in relation to the service and/or product provided;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Rami Abdelmalek, in response to an investigation by the Ontario College of Pharmacists (the “College”) into his conduct at Westboro Pharmasave in Ottawa, Ontario committed professional misconduct, in that he:

• Provided falsified employment records and/or other pharmacy records to the College;
• Provided false and/or misleading information to the College in written submissions, emails, and/or other correspondence; and/or
• Refused to provide relevant documents to College investigators upon request.

In particular, it is alleged that he:

• Contravened the Regulated Health Professions Act, 1991, as amended, and in particular:
  • Subsections 76(3) and 76(3.1) of the Health Professions Procedural Code to the Regulated Health Professions Act, 1991;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Angelo Arciero, from in or about January 2012 to in or about December 2018, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Wellcare Heartlake Pharmacy (the “Pharmacy”) in Brampton, Ontario, committed professional misconduct in that he billed, or issued bills, for products that were never dispensed to Patient 1, Patient 2 and/or Patient 3.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients and/or his practice;
• Falsified a record relating to his patients and/or his practice;
• Signed or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false or misleading statement;
• Submitted or permitted, consented to or approved, expressly or by implication, the submissions of an account or charge for products that he knew and/or ought to have known was false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Angelo Arciero, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Wellcare Heartlake Pharmacy (the “Pharmacy”) in Brampton, Ontario, committed professional misconduct in that he:

• Failed to keep records as required respecting his patients and/or practice with respect to certain identified drug products;
• Falsified a record relating to his patients and/or his practice with respect to certain identified drug products;
• Signed or issued, in his professional capacity, a document he knew and/or ought to have known contained a false and misleading statement with respect to certain identified drug products;
• Submitted or permitted, consented to or approved, expressly or by implication, the submissions of an account or charge for products that he knew and/or ought to have known was false or misleading with respect to certain identified drug products;
• Billed, or issued bills, for products that were never dispensed for certain identified drug products;
• Prescribed and/or dispensed the drug product Blexten to himself for his own use.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients and/or his practice;
• Falsified a record relating to his practice and/or a person’s health record;
• Signed or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false or misleading statement;
• Submitted an account or charge for services or products that he knew and/or ought to have known was false and/or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Amani Awad committed professional misconduct in that she:

• Attempted to bribe, interfere, obstruct, threaten, and/or tamper with one or more witnesses in a hearing before the Discipline Committee of the Ontario College of Pharmacists regarding allegations of professional misconduct against her.

In particular, it is alleged that she:

• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional;
• Engaged in conduct that is unbecoming a member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mary Azzer, while engaged in the practice of pharmacy as Designated Manager and/or dispensing pharmacist at Family Care Pharmacy in Iroquois Falls, Ontario (the “Pharmacy”), and/or as a shareholder and/or director of the corporation that operates the Pharmacy, committed professional misconduct in that:

• On or about June 12, 2019, she permitted, consented to or approved, expressly or impliedly, the Pharmacy operating without a pharmacist being physically present;
• On or about June 12, 2019, she permitted, consented to or approved, expressly or impliedly, the sale and/or dispensing of drugs at the Pharmacy while no pharmacist was physically present, with respect to certain identified prescriptions;
• On or about June 12, 2019, she permitted, consented to or approved, expressly or impliedly, the dispensing of new prescriptions to patients without the patients being offered counselling by a pharmacist, with respect to certain identified prescriptions;
• On or about June 12, 2019, she permitted, consented to or approved, expressly or impliedly, the dispensing of prescriptions to patients without the prescriptions having been checked appropriately by a pharmacist, with respect to certain identified prescriptions;
• On or about June 12, 2019, she signed prescription hardcopies as dispensing pharmacist without having appropriately checked the prescriptions before they were dispensed to patients, with respect to certain identified prescriptions;
• On or about June 12, 2019, she delayed the dispensing of a methadone prescription to a patient experiencing acute opioid withdrawal, rather than directing the person presenting the prescription to a nearby pharmacy that could fill it promptly.

In particular, it is alleged that she:

• Failed to maintain a standard of practice of the profession;
• Falsified a record relating to her practice or a person’s health record;
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular s. 146 and s. 149 of the Drug and Pharmacies Regulation Act;
• Contravened a federal, provincial or territorial law or municipal by-law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, and in particular s. C.01.041 of the Food and Drug Regulations, CRC, c 870, made under the Food and Drugs Act;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Pedro Barreiro, as Designated Manager and sole director and shareholder of the corporation that owned and operated Shoppers Drug Mart, located on 1821 Robertson Road in Ottawa, Ontario, committed professional misconduct in that he:

• Maintained prescription hardcopies that were missing pharmacist signatures in respect of approximately 1267 transactions, from on or about 2015, to on or about September 10, 2018; and/or
• Completed pharmacist-authorized prescription renewals for controlled substances that he did not have the authority to renew in respect of approximately 48 transactions, from on or about January 1, 2017, to on or about September 7, 2018; and/or
• Completed pharmacist-authorized prescription renewals for which he maintained incomplete or insufficient documentation in respect of approximately 352 transactions, from on or about July 22, 2016, to on or about June 21, 2018; and/or
• Submitted bills for MedsChecks transactions which he did not complete in respect of:
  1. 44 MedsChecks billed on September 26, 2016; and/or
  2. 28 MedsChecks billed on September 30, 2016; and/or
  3. 26 MedsChecks billed on December 28, 2017; and/or
• Failed to properly maintain MedsChecks documentation as required in respect of:
  1. 44 transactions billed on or about September 26, 2016; and/or
  2. 28 transactions billed on or about September 30, 2016; and/or
  3. 26 transactions billed on or about December 28, 2017; and/or
  4. 40 transactions billed from on or about February 17, 2017, to on or about August 11, 2018; and/or
  5. 12 MedsChecks Patient Acknowledgement Forms which were inaccurately dated or undated; and/or
• Failed to document notification of, and/or notify patients’ primary care providers as required, with respect to 51 MedsChecks transactions, from on or about October 1, 2016, to on or about September 10, 2018; and/or
• Failed to document notification of, and/or notify patients’ prescribers as required, with respect to 403 pharmacist-authorized prescription renewals, from on or about January 1, 2016, to on or about September 10, 2018; and/or
• Failed to document notification of, and/or notify the prescriber of patient [Name], as required, with respect to 18 pharmacist-authorized prescription renewals, from on or about December 4, 2017, to on or about April 2, 2018.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients;
• Falsified a record related to his practice or a person’s health record;
• Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
• Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Pedro Barreiro, committed professional misconduct in that he:

• Failed to report to the College that he had been charged with a criminal offence (having care and control of a motor vehicle while “over 80”, contrary to section 253(1)(b) of the Criminal Code) on May 22, 2013, and/or that he had been convicted of that offence on May 29, 2014;
• On his annual renewal form submitted on or about March 5, 2014, he falsely answered “no” on his 2014 College Annual Renewal Form, to the question “are you the subject of a current proceeding in respect of any offence in any jurisdiction?”; and/or on his annual renewal form submitted on or about March 9, 2015, he falsely answered “no” on no 2015 College Annual Renewal Form, to the question “since your last declaration to the College, have you been found guilty of any offence in any jurisdiction?”

In particular, it is alleged that he:

• Contravened a term, condition or limitation imposed on his certificate of registration;
• Signed or issued, in his professional capacity, a document that the he knew contained a false or misleading statement;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Dumfour David Berko, while engaged in the practice of pharmacy as Designated Manager and/or dispensing pharmacist at the […] Pharmacy in […], Ontario, in the period from about [Identified Date A] to [Identified Date B], committed professional misconduct in that he:

• Sexually abused a patient, […]
• Failed to maintain appropriate professional boundaries with a patient, […]
• Provided a scheduled drug (Tylenol #3) to a patient, […], without a validly authorized prescription.

In particular, it is alleged that he:

• Sexually abused a patient;
• Failed to maintain a standard of practice of the profession;
• Contravened s. 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
• Contravened a federal or provincial law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, specifically s. 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4, and s. 31(1) of the Narcotic Control Regulations, C.R.C., c. 1041;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

A motion in this matter was heard on April 27, 2021.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Dejan Buric, as a dispensing pharmacist and/or Designated Manager at Olde Walkerville Pharmacy at 1701 Wyandotte Street East in Windsor (the Pharmacy), committed professional misconduct with respect to the following:

• False or unsubstantiated claims submitted to the Ontario Drug Benefit Program (ODB) from the Pharmacy from approximately February 1, 2016 to approximately August 22, 2017 for seven identified drugs, or any of them; and/or
• Improper claims for prescriptions and/or other products submitted to the ODB from the Pharmacy in relation to one or more of certain identified claims.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
  • sections 5, 15, 17 and/or 23 of the Ontario Drug Benefit Act and/or;
  • sections 18, 25 and 29(1) of Ontario Regulation 201/96, and/or;
  • section 166 of the Drug and Pharmacies Regulation Act;
• Failed to keep records as required respecting his patients;
• Falsified a record relating to his practice;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Alexander Chan, while practising pharmacy as a staff pharmacist and owner at [the Pharmacy], committed professional misconduct in that:

• On or about [date], he sexually assaulted a volunteer at the Pharmacy, [Name];
• On October 15, 2020, he was found guilty of sexual assault contrary to section 271 of the Criminal Code of Canada.

In particular, it is alleged that he:

• Was found guilty of an offence that is relevant to his suitability to practice;
• Engaged in conduct that is unbecoming of a Member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Alexander Chan, while practising pharmacy as a staff pharmacist and owner at [the Pharmacy], committed professional misconduct in the period of [specified date ranges], in that he:

• Made unwelcome comments of a sexual nature towards his co-worker and employee, [Co-Worker]; and/or
• On one or more occasions, he touched inappropriately or attempted to touch inappropriately his co-worker and employee, [Co-Worker].

In particular, it is alleged that he:

• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional;
• Engaged in conduct that is unbecoming of a Member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Augustine Daniar, since May 2019, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at White Cedar Pharmacy in Thunder Bay, Ontario, committed professional misconduct in that he:

• Failed to keep records as required relating to his patients and/or his practice with respect to the drug product Suboxone;
• Falsified a record relating to his patients and/or his practice with respect to the drug product Suboxone;
• Signed or issued, in his professional capacity, a document he knew and/or ought to have known contained a false and misleading statement with respect to the drug product Suboxone;
• Submitted or permitted, consented to or approved, expressly or by implication, the submissions of an account or charge for products that he knew and/or ought to have known was false or misleading with respect to the drug product Suboxone.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients and/or his practice;
• Falsified a record relating to his patients and/or his practice;
• Signed or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false or misleading statement;
• Submitted or permitted, consented to or approved, expressly or by implication, the submissions of an account or charge for products that he knew and/or ought to have known was false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Amin Dharamsi, while engaged in the practice of pharmacy as a Designated Manager and/or dispensing pharmacist at [the Pharmacy], and/or as a director and/or shareholder of the corporation that owned and/or operated the Pharmacy, committed professional misconduct with respect to the following incidents:

• Between about October 2, 2018 and January 23, 2019, he failed to take appropriate steps to ensure the destruction of narcotics, controlled drugs, and/or targeted substances;
• On at least one occasion between about October 2, 2018 and January 23, 2019, he asked staff member [Person A] to destroy narcotics, controlled drugs, and/or targeted substances in his absence and/or in a manner contrary to Health Canada’s guidelines for the destruction of narcotics, controlled drugs, and/or targeted substances;
• On one occasion between about October 2, 2018 and January 23, 2019, he removed narcotics, controlled drugs, and/or targeted substances from the Pharmacy’s premises without appropriate documentation and/or justification;
• Between about October 2, 2018 and January 23, 2019, he provided routine pharmaceutical care and/or dispensed prescriptions to himself and to family members;
• On multiple occasions between about October 2, 2018 and January 23, 2019, he attempted to create false and/or misleading pharmacy records by attempting to imitate the signature of another pharmacist on dispensing records, and/or he asked members of the Pharmacy’s staff to assist him in doing so;
• On or about November 1, 2018, he attempted to create false and/or misleading pharmacy records showing the dispensing of medication to patient [Patient 1] at a greater frequency than was actually dispensed, and/or he asked members of the Pharmacy’s staff to assist him in doing so;
• On at least one occasion between about October 2, 2018 and January 23, 2019, he asked members of the Pharmacy’s staff to dispense, and/or to assist in the dispensing of, drugs without the markings on the container required by s. 156(3) of the Drug and Pharmacies Regulation Act, RSO 1990, c H.4;
• On at least two occasions between about October 2, 2018 and February 8, 2019, he gave previously-dispensed drugs and/or products to members of the Pharmacy’s staff and asked that they return the drugs and/or products to the Pharmacy’s inventory for resale;
• On at least one occasion between about October 2, 2018 and January 23, 2019, he asked members of the Pharmacy’s staff to falsify, and/or to assist him in falsifying, frequency of dispensing forms, and in particular with respect to falsifying the date on which the forms were sent to prescribers;
• On at least one occasion between about October 2, 2018 and January 23, 2019, he asked members of the Pharmacy’s staff to falsify, and/or to assist him in falsifying, the Pharmacy’s records relating to documenting the calibration of the Pharmacy’s scale and/or the temperature of the Pharmacy’s refrigerator;
• On multiple occasions between about [specified date A] and [specified date B], he behaved inappropriately toward and/or in the presence of members of the Pharmacy’s staff, including with respect to the following:
  1. he raised his voice, and/or threw objects, and/or shouted, at members of the Pharmacy’s staff;
  2. he hugged and/or kissed staff member [Person B];
  3. he asked staff member [Person B] inappropriately personal questions;
  4. he harassed staff members[ Person B] and [Person A] by persistently contacting them outside of their working hours at their personal contact numbers and/or email addresses;
• On at least one occasion between about October 2, 2018 and January 23, 2019, he practised the profession while his ability to do so was impaired or adversely affected by a substance, condition, dysfunction, disorder or circumstance, including but not limited to Nabilone and/or Suboxone;
• On multiple occasions between about October 2, 2018 and January 23, 2019, including on December 18, 2018, December 20, 2018, and/or January 4, 2019, he referred to himself by the title “Doctor” or an abbreviation thereof, and/or he represented himself as holding the educational degree of Doctor of Pharmacy by using the abbreviation “Pharm. D” after his name, without justification or authority;
• Between about October 2, 2018 and January 23, 2019, he dispensed (or permitted, consented to or approved, expressly or impliedly, the dispensing of) certain identified medication to patients in combinations of strengths that were inappropriate having regard to the patients’ prescribed doses and the available strengths of the medications, without an appropriate clinical, therapeutic, or other reasonable basis;
• Between about October 2, 2018 and January 23, 2019, he charged (or permitted, consented to or approved, expressly or impliedly, the charging of) amounts that were excessive in relation to the service or product provided, and in particular, he charged dispensing fees for dispensing certain identified medication to patients in combinations of strengths that were inappropriate having regard to the patients’ prescribed doses and the available strengths of the medications, without an appropriate clinical, therapeutic, or other basis.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Practised the profession while his ability to do so was impaired or adversely affected by any substance, condition, dysfunction, disorder or circumstance that he knew or ought to have known would impair or adversely affect his ability to practice;
• Inappropriately used a term, title or designation in respect of his practice;
• Charged a fee or amount that was excessive in relation to the service or product provided;
• Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professionals Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those acts, and in particular s. 33(1) of the Regulated Health Professions Act, 1991, SO 1991, c 18;
• Contravened a federal, provincial, or territorial law or municipal by-law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, and in particular s. 43 of the Narcotic Control Regulations, CRC, c 1041;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Michael El Rabeb, while engaged in the practice of pharmacy as owner, director, shareholder, and/or dispensing pharmacist at Westboro Pharmasave in Ottawa, Ontario, committed professional misconduct in that he:

• Submitted (or permitted, consented to, or approved, expressly or by implication, the submissions of) claims with excessive markups for one or more of certain identified drugs and/or products from in or about November 1, 2016 to in or about April 30, 2018;
• Submitted (or permitted, consented to, or approved, expressly or by implication, the submissions of) claims to multiple plans where one or more of those plans was not obligated to pay the claim (or the full amount of the claim) for one or more of certain identified drugs and/or products from in or about November 1, 2016 to in or about April 30, 2018; and/or
• Submitted (or permitted, consented to or approved, expressly or by implication, the submissions of) claims for dispensing fees for compliance packages at more frequent intervals than the compliance packages were being dispensed for one or more patients from in or about May 1, 2018 to in or about April 24, 2019.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients and/or practice;
• Falsified a record relating to his practice and/or a person’s health record;
• Signed and/or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false and/or misleading statement;
• Submitted an account and/or charge for services and/or products that he knew and/or ought to have known was false and/or misleading;
• Charged a fee and/or amount that was excessive in relation to the service and/or product provided;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Michael El Raheb, in response to an investigation by the Ontario College of Pharmacists (the “College”) into his conduct at Westboro Pharmasave in Ottawa, Ontario, committed professional misconduct in that he:

• Provided falsified employment records and/or other pharmacy records to the College;
• Provided false and/or misleading information to the College in written submissions, emails, and/or other correspondence; and/or
• Refused to provide relevant documents to College investigators upon request.

In particular, it is alleged that he:

• Contravened the Regulated Health Professions Act, 1991, as amended, and in particular:
  • Subsections 76(3) and 76(3.1) of the Health Professions Procedural Code to the Regulated Health Professions Act, 1991;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Shereen El-Azrak committed professional misconduct in that

• On September 25, 2018, in the Superior Court of Justice at Newmarket, she was found guilty of trafficking in fentanyl and possession of fentanyl for the purpose of trafficking, contrary to s. 5 of the Controlled Drugs and Substances Act, S.C. 1996, c. 19.

In particular, it is alleged that she

• Was found guilty of offences that are relevant to her suitability to practice.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Babatunde Fashina, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager, shareholder and/or director at Thistle Pharmacy in Brampton, Ontario, from about January 1, 2017 to December 31, 2020, committed professional misconduct in that he:

• Submitted false claims for one or more of certain identified drugs and other products that were not actually dispensed to patients; and
• Failed to keep records as required with respect to purchase invoices for certain identified drugs.

In particular, it is alleged that he:

• Failed to maintain the standards of practice of the profession;
• Failed to keep records as required respecting his patients or practice;
• Falsified records relating to his practice;
• Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
• Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular:
  • ss. 155 and 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended;
  • ss. 19(k) and 20(1), para. 4 of Ontario Regulation 264/16, made under the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mahwish Fayyaz, while engaged in the practice of pharmacy as dispensing pharmacist at Permanent Drug Mart in Rexdale, Ontario (the “Pharmacy”), committed professional misconduct in that she:

• Provided a controlled drug, as defined in the Food and Drug Regulations, […] without first having been provided a prescription for it;
• Possessed substances included in Schedule I of the Controlled Drugs and Substances Act without being authorized to do so under the Regulations of that Act;
• Provided narcotics […] otherwise than in accordance with the Regulations of the Controlled Drugs and Substances Act;
• Falsified a record relating to her patients and/or her practice with respect to certain identified narcotic drug products;
• Performed an otherwise authorized controlled act for an improper purpose with respect to certain identified narcotic drug products;
• Signed or issued, in her professional capacity, a document she knew and/or ought to have known contained a false and misleading statement with respect to certain identified narcotic drug products;
• Submitted or permitted, consented to or approved, expressly or by implication, the submissions of an account or charge for products that she knew and/or ought to have known was false or misleading with respect to certain identified narcotic drug products;
• Engaged in behavior which caused and/or resulted in patients receiving contaminated drug preparations and/or incorrect doses of narcotic drug products and/or pharmacy products that were not purchased or prescribed;

In particular, it is alleged that she:

• Failed to maintain a standard of practice of the profession;
• Performed an otherwise authorized controlled act for an improper purpose;
• Falsified a record relating to her patients and/or her practice;
• Signed or issued, in her professional capacity, a document that she knew and/or ought to have known contained a false or misleading statement;
• Submitted or permitted, consented to or approved, expressly or by implication, the submissions of an account or charge for products that she knew and/or ought to have known was false or misleading;
• Contravened, while engaged in the practice of pharmacy at the Pharmacy, a federal, provincial, or territorial law or municipal by-law, including:
  • Section G.03.002 of the Food and Drug Regulations, C.R.C., c. 870, as amended;
  • Section 4 of the Controlled Drugs and Substances Act, S.C. 1996, c.19, as amended;
  • Section 31(1) of the Narcotic Control Regulations under the Controlled Drugs and Substances Act;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that John Gerges, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Totten Pharmacy in Windsor, Ontario, and/or director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Jimmy’s Pharmacy in Toronto, Ontario, and/or director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Pacific Pharmacy in Toronto, Ontario committed professional misconduct in that he:

• Submitted (or permitted, consented to or approved, expressly or by implication, the submissions of) charges for drugs and/or products that were never dispensed for one or more of certain identified drugs and/or products;
• Falsified (or permitted, consented to or approved, expressly or by implication, the falsification of) pharmacy records regarding one or more of certain identified drugs and/or products;
• Forged (or permitted, consented to or approved, expressly or by implication, the forgery of) prescriptions using a stolen prescription pad to support charges for one or more of certain identified drugs/and or products;
• Failed to keep records as required regarding one or more of certain identified drugs and/or products; and/or
• Submitted (or permitted, consented to or approved, expressly or by implication, the submissions of) charges for approximately 755 claims for drugs, products, and/or fees in excess of the allowable amounts and/or markups permitted by [Claims Adjudicator].

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients and/or practice;
• Falsified a record relating to his practice and/or a person’s health record;
• Signed or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false or misleading statement;
• Submitted an account or charge for services and/or products that he knew and/or ought to have known was false or misleading;
• Charged a fee and/or amount that was excessive in relation to the service and/or product provided;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that John Gerges, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Totten Pharmacy in Windsor, Ontario, and/or director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Mill Street Pharmacy in Tillbury, Ontario (collectively, the “Pharmacies”), and/or while engaged in conduct outside the Pharmacies, committed professional misconduct in that he:

• Misappropriated, diverted, and/or sold without authorization one or more of certain identified controlled substances, including controlled substances obtained through one or more of the Pharmacies;
• Misappropriated, possessed without authorization, and/or fabricated one or more prescription pads purportedly belonging to a regulated health professional and/or health facility; and/or
• Misappropriated, possessed without authorization, and/or fabricated one or more prescriptions that falsely indicated that a physician had authorized the prescription.

In particular, it is alleged that he:

• Contravened a federal, provincial or territorial law or municipal by-law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, whose purpose is to protect or promote public health, and/or that is otherwise relevant to his suitability to practise, and in particular:
  1. Possession of a controlled substance for the purpose of trafficking, contrary to section 5(2) of the Controlled Drugs and Substances Act;
  2. Possession of a forged document, contrary to section 368 of the Criminal Code;
  3. Possession of the proceeds of crime exceeding $5,000, contrary to sections 354 and/or 355 of the Criminal Code; and/or
  4. Failure to comply with a release order, contrary to section 145(5) of the Criminal Code;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional;
• Engaged in conduct that is unbecoming a member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Maged Hanna, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at 3M Drug Mart (the “Pharmacy”) in Thornhill, Ontario, committed professional misconduct in that he:

1. Submitted (or permitted, consented to or approved, expressly or by implication, the submissions of) an account or charge for services or products that he knew and/or ought to have known was false or misleading with respect to:
   1. one or more of certain identified drugs and/or; and/or,
   2. one or more of certain identified claims to the Ontario Drug Benefit Program; and/or,
2. Falsified a record relating to his patients and/or his practice with respect to:
   1. one or more of certain identified drugs and/or products; and/or,
   2. one or more of certain identified claims to the Ontario Drug Benefit Program; and/or,
3. Signed or issued, in his professional capacity, a document he knew and/or ought to have known contained a false and misleading statement with respect to:
   1. one or more of certain identified drugs and/or products; and/or,
   2. one or more of certain identified claims to the Ontario Drug Benefit Program; and/or,
4. Failed to keep records as required respecting his patients and/or his practice with respect to:
   1. one or more of certain identified drugs and/or products; and/or,
   2. one or more of certain identified claims to the Ontario Drug Benefit Program;
5. Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs with respect to:
   1. one or more of certain identified drugs and/or products; and/or
   2. one or more of certain identified claims to the Ontario Drug Benefit Program.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients and/or his practice;
• Falsified a record relating to his patients and/or his practice;
• Signed or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false or misleading statement;
• Submitted (or permitted, consented to or approved, expressly or by implication, the submissions of) an account or charge for services or products that he knew and/or ought to have known was false or misleading;
• Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
  • section 15 of the Ontario Drug Benefit Act;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Nhu (Vivian) Huynh, while engaged in the practice of pharmacy as a pharmacist at Loblaw Pharmacy located at 875 Highland Road West in Kitchener, Ontario (the “Pharmacy”), committed professional misconduct in that she:

• Removed without authority and/or misappropriated influenza vaccines from the Pharmacy;
• Participated in the unauthorized transport, storage and/or administration of influenza vaccinations;
• Participated in the transport of influenza vaccinations in a manner that had the potential to break the cold chain and/or compromise the safety and/or the efficacy of influenza vaccinations;
• Suggested and/or offered to falsify influenza vaccination records and/or patient records;
• Delayed, limited and/or restricted her patients’ access to influenza vaccinations; and/or
• Acted in a conflict of interest with respect to influenza vaccinations.

In particular, it is alleged that she:

• Failed to maintain a standard of practice of the profession;
• Practiced the profession while in a conflict of interest and/or participated in an arrangement that constitutes a conflict;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that John Kaldus, while practicing pharmacy as Designated Manager, director and shareholder, and/or dispensing pharmacist at Elliot Lake Health Centre Pharmachoice in Elliot Lake, Ontario and/or Robinson’s Pharmasave in Espanola, Ontario, in the period from about August 2014 to February 2018, committed professional misconduct in that he:

• Failed to keep records as required by the College’s Medication Procurement and Inventory Management Policy with respect to the inventory of narcotics and controlled drugs;
• Directed non-pharmacist employees to dispense methadone to patients;
• Misappropriated prescription drugs and/or controlled substances from the pharmacy, including:
  • Oxycocet;
  • Tylenol #3 and/or Ratio-Lenoltec #3;
  • Clonazepam; and/or
  • Tramadol.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required;
• Contravened s. 149(1) of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
• Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, specifically
  • s. 4 of the Controlled Drugs and Substances Act;
  • s. 51(1) of the Benzodiazepines and Other Targeted Substances Regulations, SOR/2000-217;
  • s. 31(1) of the Narcotic Control Regulations, C.R.C., c. 1041
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that John Kaldus, while practicing pharmacy as Designated Manager, director and shareholder, and/or dispensing pharmacist at Elliot Lake Health Centre Pharmachoice in Elliot Lake, Ontario and/or Robinson’s Pharmasave in Espanola, Ontario, in the period from about December 2015 to April 2019, committed professional misconduct in that he:

• Failed to report to the Registrar that he had been charged criminally with offences under the Controlled Drugs and Substances Act on or about December 24, 2015;
• Unlawfully possessed the following controlled substances without a prescription when stopped by police in King Township, Ontario on December 24, 2015:
  • Oxycontin;
  • Oxycocet;
  • Oxycodone; and/or
  • Morphine.

In particular, it is alleged that he:

• Contravened a term, condition or limitation imposed on his certificate of registration;
• Failed to maintain a standard of practice of the profession;
• Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, specifically:
  • s. 4 of the Controlled Drugs and Substances Act, S.C. 1996, c. 19;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Shamez Kassam, while engaged in the practice of pharmacy as dispensing pharmacist and/or a director and/or shareholder of the corporation that owned and/or operated Chapmans Pharmacy in London, Ontario (the “Pharmacy”), committed professional misconduct with respect to the following:

• At various times between about February 2010 and June 12, 2019, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for drugs and/or products that were not dispensed, including:
  1. by instructing staff (or permitting, consenting to or approving, expressly or impliedly, the instruction to staff) to not cancel prescriptions that had been billed but not dispensed to patients, and/or
  2. with respect to certain identified drugs and/or;
• Between about October 1, 2017 and November 30, 2017, he cancelled (or permitted, consented to or approved, expressly or impliedly, the cancellation of) prescriptions for which the Pharmacy was not entitled to payment, without taking the steps (or ensuring the steps were taken) that were necessary to ensure the reversal of the charges billed by the Pharmacy, with respect to certain identified prescriptions;
• Between about September 1, 2015 and October 1, 2017, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) certain identified claims to the Ontario Drug Benefit Program for which he was required to have and maintain records that he did not have and/or maintain;
• Between about September 1, 2015 and October 1, 2017, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) certain identified claims to the Ontario Drug Benefit Program and accepted payment for those claims without being entitled to payment;
• At various times between about February 2010 and June 12, 2019, he instructed staff to dispense methadone and/or Suboxone to patients without a pharmacist present to witness the patient’s dose, and/or he participated in, permitted, consented to, or approved, either expressly or impliedly, that practice;
• At various times between about February 2010 and June 12, 2019, he instructed staff to dispense prescription medication to patients without ensuring that a pharmacist or registered pharmacy technician had verified the prescription and its preparation, and had signed the prescription hardcopy, and/or he participated in, permitted, consented to, or approved, either expressly or impliedly, that practice;
• At various times between about February 2010 and June 12, 2019, he instructed staff to sign prescription hardcopies in a manner intended to or that he ought reasonably to have expected would be confused for a pharmacist’s signature, and/or he participated in, permitted, consented to, or approved, either expressly or impliedly, that practice;
• At various times between about May 27, 2014 and June 12, 2019, he failed to ensure appropriate staffing levels in the Pharmacy to enable himself and other staff to maintain the accepted standard of pharmacy practice and to deliver safe and effective patient care;
• Between about December 2016 and February 2017, he instructed staff to dispense reconstituted powdered methadone to patients while billing those patients’ prescriptions as though Methadose had been dispensed, and/or he participated in, permitted, consented to, or approved, either expressly or impliedly, that practice;
• Between about January 1, 2016 and December 31, 2018, he failed to report (or ensure the reporting of) a loss or theft of narcotics relating to losses of Hydromorph contin 18mg, 24mg, and/or 30mg, as required by s. 42 of the Narcotic Control Regulations, CRC, c. 1041;
• Between about January 1, 2016 and June 12, 2019, he failed to ensure that inventory reconciliations of narcotics and controlled/targeted substances were performed at least every six months and/or with reasonable/required frequency.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients or practice;
• Falsified a record relating to his practice and/or to a person’s health record;
• Submitted an account or charge for services or products that he knew or ought to know was false or misleading;
• Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular:
  • s. 156(1)(g) of the Drug and Pharmacies Regulation Act, RSO 1990, c H.4;
• Contravened a federal or provincial or territorial law or municipal by-law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or mixture of drugs or product, and in particular:
  • ss. 5, 6, and/or 15(1)(b) of the Ontario Drug Benefits Act, RSO 1990, c O.10, as amended;
  • s. 42 of the Narcotic Control Regulations, CRC, c. 1041;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Babak Khazra, while engaged in the practice of pharmacy as a dispensing pharmacist at Blair Court Pharmacy (Accreditation Number 303254) in Toronto, Ontario (the “Pharmacy”), and/or as a director and shareholder of the corporation that owned and operated the Pharmacy, in or about March and April 2020, committed professional misconduct in that he:

• Submitted accounts or charges for services that he knew or reasonably ought to have known were false or misleading to the Ontario Drug Benefit program for some or all of 78 MedsCheck reviews that were never conducted and/or were non-compliant with the guidelines of the Ministry of Health and Long Term Care; and/or
• Falsified pharmacy records in relation to claims made to the Ontario Drug Benefit Program for some or all of 78 MedsCheck reviews that were never conducted and/or were non-compliant with the guidelines of the Ministry of Health and Long Term Care; and/or
• Failed to document and/or retain records for some or all of 78 MedsCheck services as required by the MedsCheck program and pharmacy regulations; and/or
• Failed to ensure the confidentiality of patient records.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Falsified a record relating to his practice or a person’s health record;
• Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
• Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
• Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular:
  • Section 15(1) of the Ontario Drug Benefit Act;
  • Sections 27 and/or 29 of O. Reg. 201/96, made under the Ontario Drug Benefit Act;
  • Sections 20 and/or 21 of O. Reg. 264/16, made under the Drug and Pharmacies Regulation Act; and/or
  • Section 12 of the Personal Health Information Protection Act, 2004;
• Failed to keep records as required respecting his patients or practice;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Hany Komy, while engaged in the practice of pharmacy as […] at [the Pharmacy] in […], Ontario, committed professional misconduct in that he:

• Failed to maintain a professional boundary in respect of patient [Name], in the period from about [Specified Date 1] to [Specified date 2];
• Dispensed controlled-release oxycodone to patient [Name] on or about [Date A], [Date B], [Date C], and/or [Date D], instead of the short-acting oxycodone that had been prescribed.

In particular, it is alleged that he:

• Sexually abused a patient, [Name];
• Failed to maintain a standard of practice of the profession;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Jaak Kubar, as dispensing pharmacist and/or Designated Manager of Burlington Drug Mart at 701 Guelph Line in Burlington, Ontario (the Pharmacy), and/or as a shareholder of the corporation that owned the Pharmacy, committed professional misconduct between approximately January 31, 2018 and July 31, 2020, in that he:

• Dispensed narcotic prescriptions to a single patient from two or more different prescribers without exercising appropriate professional diligence, communicating pertinent information to prescribers, and/or making adequate inquiries with the prescribers for one or more of certain identified drugs;
• Dispensed a monitored drug to one or more patient(s) without submitting the required information to the Narcotics Monitoring System as required by s. 8 of the Narcotics Safety and Awareness Act, 2010, S.O. 2010, c.22 and the Notice issued thereunder for one or more of certain identified transactions;
• Failed to adequately document the actions, if any, taken in response to, and/or the reasons for not taking any action in response to, one or more of certain identified Narcotics Monitoring System alerts; and/or
• Permitted and/or assisted a patient to conceal authorizations for Schedule I controlled substances from another prescriber, contrary to s. 4(2) of the Controlled Drugs and Substances Act.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required with respect to his patients or practice;
• Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular: s. 8 of the Narcotics Safety and Awareness Act, 2010, S.O. 2010, c.22;
• Permitted, consented to, approved, counselled or assisted, whether expressly or by implication, the commission of an offence against any Act relating to the practice of pharmacy or the sale of drugs;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Peter Leung (OCP #82856), as staff pharmacist and/or Designated Manager at Sobeys Pharmacy in Simcoe, Ontario (“Pharmacy”), committed professional misconduct in that he:

• Submitted claims for dispensing fees bi-weekly for compliance pack medications that were dispensed to patients monthly, including transactions for certain identified patients, in or about June 2016-July 2019;
• Falsified records in relation to dispensing compliance pack medications as though dispensed bi-weekly when the medications were dispensed monthly, including transactions for certain identified patients, in or about July 2016-July 2019;
• Failed to submit cancelled claims, to be reversed manually by the Ontario Drug Benefit Program (“ODB”), within a reasonable period of time, including certain identified transactions, in or about November 2018-January 2019;
• Failed to reverse claims for medications intended for the patients, […], […] and/or […], but not dispensed to the patients prior to the Pharmacy being notified the patients had died, in or about November 2018-June 2019;
• Falsified records in relation to the patients, […], […] and/or […] to indicate the medications intended for the patients before they died had been picked up from the Pharmacy despite prior notice to the Pharmacy regarding the deaths, in or about November 2018-June 2019; and/or
• Submitted claims to the ODB that included markups on drug costs in excess of the markups permitted by the ODB, in relation to approximately 700 claims, in or about January 2019-July 2019, contrary to the Ontario Drug Benefit Act and regulations thereunder, including approximately 190 claims taking improper advantage of coordination of benefits with the patients’ other benefit plans.

In particular, it is alleged that he:

• Failed to maintain a standard of practice;
• Falsified a record relating to his practice or a person’s health record;
• Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
• Submitted an account or charge for services or products that he knew or ought to have know was false or misleading;
• Charged a fee or amount that was excessive in relation to the service or product provided;
• Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
  • The Ontario Drug Benefit Act, sections 4, 6 and/or 15, and/or
  • Ontario Regulation 201/96, sections 13, 20.1, 20.2 and/or 27;
• Contravened the Act, the Drug and Pharmacies Regulations Act, the Regulated Health Professions Act, 1991, the Narcotic Safety and Awareness Act 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular:
  • Sections 4, 6 and/or 15 of the Ontario Drug Benefit Act, R.S.O. 1990, c.O.10, as amended, and/or
  • Sections 13, 20.1, 20.2 and/or 27 of Ontario Regulation 201/96, as amended;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Yong Lin, while practicing pharmacy as the Designated Manager and/or dispensing pharmacist at the Life Compounding Pharmacy in Richmond Hill, Ontario, in the period from about August 10, 2019, to November 22, 2020, committed professional misconduct in that he:

• Failed to recognize the limits of his competence with respect to the dispensing of drugs prescribed by veterinarians and taking insufficient steps to acquire such competence; and
• Failed to exercise reasonable diligence in scrutinizing the prescriptions purportedly issued by Dr. [Name A] and Dr. [Name B].

In particular, it is alleged that he:

• Failed to maintain a standard or standards of practice;
• Performed a professional service without the requisite knowledge or skill;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Christine Martin, while employed as a pharmacy technician at Canadian Drug Mart in Barrie, committed professional misconduct in that she:

• Misappropriated narcotics, contrary to Section 4(1) of the Controlled Drugs and Substances Act, S.C. 1996, from on or about October 2018, to on or about January 28, 2019; and/or
• Falsified records with respect to the Pharmacy’s narcotics inventory, from on or about October 2018, to on or about January 28, 2019.

In particular, it is alleged that she

• Failed to maintain a standard of practice of the profession;
• Falsified a record related to her practice;
• Contravened section 4(1) of the Controlled Drugs and Substances Act, S.C. 1996;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Christine Martin committed professional misconduct in that:

• On or about December 24, 2020, she was found guilty of two counts of knowingly using a forged narcotic prescription, contrary to section 368(1)(a) of the Criminal Code of Canada;
• Obtained hydromorphone using fraudulent prescriptions on approximately thirty occasions from on or about December 3, 2018, to on or about July 10, 2019.

In particular, it is alleged that she:

• Has been found guilty of an offence that is relevant to her suitability to practise;
• Contravened sections 4(1) and 4(2)(a) of the Controlled Drugs and Substances Act, S.C. 1996;
• Engaged in conduct that is unbecoming of a member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Bichoy Maurice, as a shareholder and/or director at Olde Walkerville Pharmacy at 1701 Wyandotte Street East in Windsor, Ontario (the Pharmacy), committed professional misconduct with respect to the following:

• False or unsubstantiated claims submitted to the Ontario Drug Benefit Program (ODB) from the Pharmacy totaling approximately $720,053.73 between August 22, 2015 and August 22, 2017 for seven identified drugs, or any of them; and/or
• Improper claims for prescriptions and/or other products submitted to the ODB from the Pharmacy totaling approximately $23,894.70 in relation to one or more of certain identified claims.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
  • sections 5, 15, 17, 18 and/or 23 of the Ontario Drug Benefit Act; and/or
  • sections 18, 25 and/or 29(1) of Ontario Regulation 201/96; and/or
  • section 166 of the Drug and Pharmacies Regulation Act;
• Submitted an account or charge for services that he knew and/or ought to have known was false or misleading;
• Falsified a record relating to his practice;
• Signed or issued, in his professional capacity, a document he knew or ought to have known contained a false or misleading statement;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mina Michael, as a shareholder and/or director at Olde Walkerville Pharmacy at 1701 Wyandotte Street East in Windsor, Ontario (the Pharmacy), committed professional misconduct with respect to the following:

• False or unsubstantiated claims submitted to the Ontario Drug Benefit Program (ODB) from the Pharmacy totaling approximately $720,053.73 between August 22, 2015 and August 22, 2017 for seven identified drugs, or any of them; and/or
• Improper claims for prescriptions and/or other products submitted to the ODB from the Pharmacy totaling approximately $23,894.70 in relation to one or more of certain identified claims.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
  • sections 5, 15, 17, 18 and/or 23 of the Ontario Drug Benefit Act; and/or
  • sections 18, 25 and/or 29(1) of Ontario Regulation 201/96; and/or
  • section 166 of the Drug and Pharmacies Regulation Act;
• Submitted an account or charge for services that he knew and/or ought to have known was false or misleading;
• Falsified a record relating to his practice;
• Signed or issued, in his professional capacity, a document he knew or ought to have known contained a false or misleading statement;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Mosallam, as pharmacist and/or Designated Manager at Pars Medical Pharmacy in Richmond Hill, committed professional misconduct in that he

• Dispensed medications and/or supplies to himself, and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or falsified records of such authorization, in relation to certain identified prescriptions;
• Dispensed medications and/or supplies to himself, and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or failed to document such authorization, in relation to certain identified prescriptions;
• Dispensed medications and/or supplies to [Patient 1], and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or falsified records of such authorization, in relation to certain identified prescriptions;
• Dispensed medications and/or supplies to [Patient 1], and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or failed to document such authorization, in relation to certain identified prescriptions;
• Dispensed medications and/or supplies to [Patient 2], and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or falsified records of such authorization, in relation to certain identified prescriptions;
• Dispensed medications and/or supplies to [Patient 2], and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or failed to document such authorization, in relation to certain identified prescriptions;
• Obtained new prescriptions and/or prescription refills for himself for certain identified prescriptions;
• Dispensed prescription medications to himself in relation to certain identified prescriptions; and/or
• Submitted claims to [Insurer] for 200 diabetic test strips for himself on or about October 27, 2014, as though the prescription had been authorized by him in accordance with the regulations under the Pharmacy Act, 1991 which was not accurate, and/or then falsified a record retroactively to indicate that the claim had been authorized by a physician before being submitted.

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Practised the profession while he was in a conflict of interest
• Failed to keep records as required respecting his patients
• Falsified a record relating to his practice
• Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement
• Submitted an account or charge for services that he knew was false or misleading
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Mosallam, as pharmacist and Designated Manager at Pars Medical Pharmacy in Richmond Hill, Ontario, and as shareholder of Ultra Care Pharmacy Inc., the owner and operator of the Pharmacy, committed professional misconduct in that he

• Submitted false or unsubstantiated claims to the Ontario Drug Benefit Program totalling approximately $80,000.00 in relation to nine identified drug and/or other health products in or about January 2013-March 2015; and/or
• Created false records of billing and/or dispensing transactions in relation to the false or unsubstantiated claims submitted to the Ontario Drug Benefit Program in relation to nine identified drug and/or other health products in or about January 2013-March 2015

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Falsified a record relating to his practice
• Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement
• Submitted an account or charge for services that he knew was false or misleading
• Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, the Ontario Drug Benefit Act, R.S.O. 1990 c.O. 10, sections 5, 6 and/or 15, as amended, and/or Ontario Regulation 201/96, section 27
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Abdullah Musa, from in or about May 2016 to August 2019, while engaged in the practice of pharmacy as Designated Manager and/or dispensing pharmacist at Morrish Pharmacy in Scarborough, Ontario, committed professional misconduct in that he:

• Failed to keep records as required respecting his patients and/his practice with respect to one or more of certain identified drugs and/or products;
• Falsified a record relating to his patients and/or his practice with respect to one or more of certain identified drugs and/or products;
• Signed or issued, in his professional capacity, a document he knew and/or ought to have known contained a false and misleading statement with respect to one or more of certain identified drugs and/or products;
• Submitted or permitted, consented to or approved, expressly or by implication, the submissions of an account or charge for products that he knew and/or ought to have known was false or misleading with respect to one or more of certain identified drugs and/or products; and/or
• Charged, or issued charges, for products that were never dispensed to patients with respect to one or more of certain identified drugs and/or products.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients and/or his practice;
• Falsified a record relating to his patients and/or his practice;
• Signed or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false or misleading statement;
• Submitted or permitted, consented to or approved, expressly or by implication, the submissions of an account or charge for products that he knew and/or ought to have known was false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Jason Newman, while engaged in the practice of pharmacy as Designated Manager and/or dispensing pharmacist at Delaware Pharmacy in Delaware, Ontario (the “Pharmacy”), and/or as a shareholder and/or director of the corporation that operates the Pharmacy, committed professional misconduct in that, between May 25, 2017 and May 25, 2019, he submitted false and/or unsubstantiated claims for one or more of certain identified drugs or products.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Falsified records relating to his practice or a person’s health record;
• Submitted an account or charge for services or products that he knew or ought to know was false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Diep Nguyen, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at River Hill Pharmacy located at 2086 Lawrence Avenue West in Toronto, Ontario, committed professional misconduct with respect to:

• False or unsubstantiated claims submitted to [Insurance Provider] from the Pharmacy in or about January 2017 to in or about December 2017 totaling approximately $16,427.40 for seven identified drugs, or any of them.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients or practice;
• Falsified a record relating to his practice;
• Signed or issued, in his professional capacity, a document he knew or ought to have known contained a false or misleading statement;
• Submitted an account(s) or charge(s) for services that he knew and/or ought to have known was false or misleading;
• Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular:
  • sections 155, 163, and 166 of the Drug and Pharmacies Regulation Act; and
  • sections 18, 19, and 20 of Ontario Regulation 264/16;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofession

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Vu Nguyen, while engaged in the practice of pharmacy as Designated Manager, Director, owner and/or shareholder of Deer Ridge Pharmacy located at B-4281 King St. East in Kitchener, Ontario (the “Pharmacy”), committed professional misconduct in that he:

• Participated in the diversion and/or misappropriation of influenza vaccines to the Pharmacy;
• Administered influenza vaccinations for which there was a potential break in the cold chain and/or which may have been compromised;
• Stored and/or administered influenza vaccinations in an unsafe location or manner;
• Suggested and/or offered to falsify influenza vaccination records and/or patient records; and/or
• Practiced the profession while in a conflict of interest and/or participated in an arrangement that constitutes a conflict of interest.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Practiced the profession while in a conflict of interest and/or participated in an arrangement that constitutes a conflict of interest;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Samuel Osaseri, while engaged in the practice of pharmacy as Designated Manager and/or dispensing pharmacist, committed professional misconduct in that he:

• Sexually abused a patient, [Person A];
• Sexually harassed one or more of the following pharmacy employees: [Person B], [Person C], [Person A], [Person D], [Person E]; and/or sexually abused patient/employee [Person A].

In particular, it is alleged that he:

• Sexually abused a patient;
• Failed to maintain a standard of practice of the profession;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Manish Patel, in his role as pharmacist, director and/or shareholder at Superseven Pharmacy, committed professional misconduct with respect to the making of, labelling of, sale or dispensing of and/or recordkeeping for the Energy Booster secretagogue.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients or practice;
• Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, in particular but not limited to the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4, and Ontario Regulation 264/16 under that Act;
• Contravened any federal, provincial or territorial law or municipal by-law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, in particular but not limited to the Natural Health Products Regulations, SOR/2003-196;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Dhaval Kiranbhai Patel, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Shoppers Drug Mart Pharmacy in Windsor, committed professional misconduct in that he:

• Directed (or permitted, consented to, or approved, expressly or by implication) a pharmacy technician to perform controlled acts limited to pharmacists and/or perform acts outside her scope of practice, including but not limited to, performing the clinical verification/therapeutic check of dispensed prescriptions;
• Failed to clinically verify or perform a therapeutic check on dispensed prescriptions;
• Falsified (or directed, permitted, consented to, or approved, expressly or by implication, the falsification of) records indicating that he had performed the clinical verification/therapeutic check of dispensed prescriptions; and/or
• Failed to take reasonable steps to protect narcotics and/or controlled substances at the Pharmacy from loss or theft, including but not limited to, failing to conduct, and/or maintain a record of, adequate reconciliations for narcotics and/or controlled substances and/or failing to report losses to Health Canada as required.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to provide an appropriate level of supervision to a person he was professionally obligated to supervise;
• Failed to keep records as required respecting his patients and/or his practice;
• Falsified a record relating to his patients and/or his practice;
• Signed or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false or misleading statement;
• Contravened a federal law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, whose purpose is to protect or promote public health, and/or that is otherwise relevant to his suitability to practise, and in particular
  • Sections 42 and 43 of the Narcotic Control Regulations, as amended;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Abdulmalik Premji, while practising pharmacy as Designated Manager, director and shareholder, and/or dispensing pharmacist at Bay Ridges Pharmacy in Pickering, Ontario, in the period from about October 2018 to July 2019, committed professional misconduct in that he

• Practised while in a conflict of interest with respect to patient [Name]; and/or
• Failed to maintain the professional boundaries of the pharmacist-patient relationship with respect to patient [Name].

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Practised the profession while in a conflict of interest;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Leon Rawa, while being a pharmacist and/or Designated Manager at Dufferin Central Pharmacy located at 1649 Dufferin St., in Toronto (the “Pharmacy”) and/or while being a director and/or shareholder of the corporation that owns and operates the Pharmacy, committed professional misconduct in that he submitted false or unsubstantiated claims for one or more of certain identified products from on or about January 1, 2018 to on or about December 31, 2018.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Falsified records relating to his practice or a person’s health record;
• Signed or issued, in his professional capacity, documents that he knew or ought to have known contained false or misleading statements;
• Submitted an account or charge for services or products that he knew or ought to have known were false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Leon Rawa, while being a pharmacist and/or Designated Manager at Dufferin Central Pharmacy located at 1649 Dufferin St., in Toronto (the “Pharmacy”) and/or while being a director and/or shareholder of the corporation that owns and operates the Pharmacy, committed professional misconduct in that he submitted false or unsubstantiated claims for one or more of certain identified products from on or about August 1, 2018 to on or about July 31, 2020.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Falsified records relating to his practice or a person’s health record;
• Signed or issued, in his professional capacity, documents that he knew or ought to have known contained false or misleading statements;
• Submitted an account or charge for services or products that he knew or ought to have known were false or misleading;
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, contrary to paragraph 23 of subsection 2(1) of Ontario Regulation 130/17, and in particular he contravened section 15(1)(b) of the Ontario Drug Benefit Act;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Bishoy Salama, while engaged in the practice of pharmacy as owner, director, shareholder, Designated Manager, and/or dispensing pharmacist at Green Pharmacy in Toronto, Ontario, Fort Frances Clinic Dispensary in Fort Frances, Ontario, and/or Pharmasave Fort Frances in Fort Frances, Ontario, committed professional misconduct in that he:

• Submitted (or permitted, consented to, or approved, expressly or by implication, the submissions of) claims for MedsChecks that were not conducted, where the required documentation was not completed, and/or were otherwise non-compliant with the requirements set forth by the Ministry of Health and Long-Term Care between in or about August 2018 and in or about October 2020;
• Provided pharmaceutical care to himself and/or signed prescription hardcopies for his own medications between in or about January 2020 and in or about December 2020; and/or
• Failed to sign prescription hardcopies for medications he dispensed, signed prescription hardcopies that he did not dispense, and/or permitted staff to dispense medications without signing prescription hardcopies between in or about August 2019 and in or about January 2021.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients and/or practice;
• Falsified a record relating to his practice and/or a person’s health record;
• Signed and/or issued, in his professional capacity, a document that he knew or ought to have known contained a false and/or misleading statement;
• Submitted an account and/or charge for services and/or products that he knew or ought to have known was false and/or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Saleh committed professional misconduct in that

• On or about September 14, 2017, he committed Sexual Assault, contrary to section 271 of the Criminal Code of Canada, for which he was found criminally guilty on March 6, 2019.

In particular, it is alleged that he

• Has been found guilty of an offence that is relevant to his suitability to practice;
• Engaged in conduct that is unbecoming a member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Shaheen while engaged in the practice of pharmacy as director, shareholder, Designated Manager and/or dispensing pharmacist in Ottawa, Ontario, committed professional misconduct in that he

• Engaged in the trafficking of controlled substance with respect to certain identified items
• Dispensed drugs and/or products for which prescriptions are legislatively required without an authorized prescriber’s authorization as set out for certain identified items
• In or about the period from January 2013 to March 2015, he failed to keep records as required by the Medication Procurement and Inventory Management Policy with respect to the inventory of narcotics and controlled drugs
• Submitted accounts or charges for services that he knew were false or misleading to the Ontario Drug Benefit program for one or more certain identified drugs and/or drug products
• Falsified pharmacy records relating to his practice in relation to claims made to the Ontario Drug Benefit program for one or more certain identified drugs and/or drug products
• From approximately January 2013 to March 2015, he used his position as pharmacist to traffic in narcotics, in particular fentanyl patches
• Procured an individual to carry out a simulated robbery of the IDA Rideau Pharmacy on October 26, 2014
• Made a report to the […] Police in respect of a robbery allegedly committed on October 26, 2014, knowing that the report was false

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Failed to keep records as required respecting his patients
• Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement with respect to the certain identified forged prescriptions
• Submitted accounts or charges for services that he knew to be false or misleading
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts with respect to the following incidents:
  • Dispensing drugs and/or products in the absence of a prescription authorized by a prescriber in contravention of s. 40 of Ontario Regulation 58/11 under the Drug and Pharmacies Regulation Act and ss. 155 and 156
• Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, and in particular, with respect to the following incidents:
  • Trafficking controlled substances in contravention of s. 5 of the Controlled Drugs and Substances Act
  • Dispensing drugs in the absence of a prescription authorized by a prescriber in contravention of s. 31 of the Narcotic Control Regulation
  • Selling drugs in the absence of a prescription authorized by a prescriber in contravention of C.01.041 of the Food and Drug Regulations
  • Selling drugs in the absence of a prescription authorized by a prescriber in contravention of G.03.002 of the Food and Drug Regulations
• Knowingly permitted the premises in which the pharmacy was located to be used for unlawful purposes
• Permitted, consented to or approved, either expressly or by implication, the commission of an offence against any Act relating to the practice of pharmacy or to the sale of drugs by a corporation of which he was a director
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Shaheen committed professional misconduct in that he

• Failed to comply with the decision of the Inquiries, Complaints and Reports Committee dated May 10, 2016, in that he failed to successfully complete the Professional Problem-Based Ethics workshop offered by the Center for Personalized Education for Physicians, at his own expense, within 12 months of the date of that decision, and provide proof thereof to the College.

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, namely: he contravened s. 26(3) of the Health Professions Procedural Code
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Shaheen, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager, shareholder and/or director at IDA Rideau Medical Pharmacy in Ottawa, Ontario, between May 2, 2011 and June 17, 2015, committed professional misconduct in that he

• Falsified pharmacy records relating to his practice in connection with claims made for certain identified drugs and/or other products and/or certain identified MedsCheck claims;
• Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement in connection with claims made for certain identified drugs and/or other products and/or certain identified MedsCheck claims;
• Submitted an account or charge for services that he knew was false or misleading in connection with claims made for certain identified drugs and/or other products and/or certain identified MedsCheck claims

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Falsified pharmacy records relating to his practice
• Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement
• Submitted an account or charge for services that he knew was false or misleading
• Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, sections 5, 6 and 15(1) of the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10, as amended
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that George Shehata, from in or about July 2018 to in or about September 2020, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at True Vine Pharmacy in Hamilton, Ontario, committed professional misconduct in that he:

• Submitted (or permitted, consented to, or approved, expressly or by implication, the submission of) an account or charge for services or products that he knew and/or ought to have known was false or misleading with respect to one or more of certain identified drugs and/or products;
• Falsified (or permitted, consented to or approved, expressly or by implication, the falsification of) a record regarding his patients and/or his practice with respect to one or more of certain identified drugs and/or products;
• Signed or issued, in his professional capacity, (or permitted, consented to, or approved, expressly or by implication, the signing or issuance of) a document he knew and/or ought to have known contained a false and/or misleading statement with respect to one or more of certain identified drugs and/or products; and/or
• Failed to keep records as required regarding his patients and/or his practice with respect to one or more of certain identified drugs and/or products.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients and/or his practice;
• Falsified a record relating to his patients and/or his practice;
• Signed or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false or misleading statement;
• Submitted (or permitted, consented to or approved, expressly or by implication, the submissions of) an account or charge for services or products that he knew and/or ought to have known was false and/or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mourcos Shenouda, as pharmacist and Designated Manager at Upper Ottawa Pharmacy (the Pharmacy), in Hamilton, Ontario, and/or as director and/or shareholder of the corporation that owns and operates the Pharmacy, committed professional misconduct in that he submitted false or unsubstantiated claims for one or more of certain identified products from on or about January 1, 2018 to on or about August 13, 2020.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Falsified records relating to his practice or a person’s health record;
• Signed or issued, in his professional capacity, documents that he knew or ought to have known contained false or misleading statements;
• Submitted an account or charge for services and products that he knew was false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Michelle Shim, since in or around June 2017, while acting as Designated Manager, dispensing pharmacist and/or in any other capacity at Innomar Specialty Pharmacy in Barrie, Ontario, APlusPharma Ltd., Innomar Strategies Inc. and/or any other corporate entity affiliated with APlusPharma and/or Innomar Strategies, committed professional misconduct in that she:

• Practised the profession while in a conflict of interest as defined in Part II of Ontario Regulation 130/17 in relation to the drug product XYREM;
• Participated in an arrangement that constitutes a conflict of interest as defined in Part II of Ontario Regulation 130/17 with respect to the drug product XYREM;
• Entered into an agreement, in relation to the drug product XYREM, that restricted a person’s choice of a pharmacist without the consent of the person;
• Solicited and/or permitted the solicitation of patients to the Pharmacy in relation to the drug product XYREM; and/or,
• Participated in the transition to dispensing XYREM to the Pharmacy exclusively through the Pharmacy in a manner that contravened the principles of Beneficence, Respect for Persons/Justice and Accountability (Fidelity) in the Ontario College of Pharmacists Code of Ethics.

In particular, it is alleged that she:

• Failed to maintain a standard of practice of the profession;
• Practised the profession of pharmacy while in a conflict of interest and/or participated in an arrangement that constitutes a conflict of interest;
• Entered into an agreement that restricted one or more persons choice of a pharmacist without the consent of those person(s);
• Solicited and/or permitted the solicitation of one or more patients to the Pharmacy;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional;
• Engaged in conduct that is unbecoming a member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Soha Shoala, while being a pharmacist and/or Designated Manager at All Care Pharmacy located in Mississauga (the “Pharmacy”) and/or while being a director and/or shareholder of the corporation that owns and operates the Pharmacy, committed professional misconduct in that she:

• Failed to keep records as required respecting her practice with respect to one or more of certain identified products from on or about January 1, 2017 to on or about December 31, 2017; and/or
• Failed to have systems in place to maintain an audit trail of the acquisition and movement of products from on or about January 1, 2017 to on or about December 31, 2017;
• Submitted false or unsubstantiated claims for one or more of certain identified products from on or about January 1, 2017 to on or about December 31, 2017.

In particular, it is alleged that she:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting her practice;
• Falsified records relating to her practice;
• Signed or issued, in her professional capacity, documents that she knew contained false or misleading statements;
• Submitted an account or charge for services and products that she knew were false or misleading;
• Contravened a regulation under the Drug and Pharmacies Regulation Act, and in particular sections 19 and 20 of Ontario Regulation 264/16;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances would reasonably be regarded members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Eddie Slama, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager, shareholder and/or director at Clairhurst Medical Pharmacy and/or CC Pharmacy, both in Toronto, Ontario, from about September 13, 2017 to May 23, 2019, committed professional misconduct in that he submitted false claims for one or more of certain identified drugs and other products when a different product was actually dispensed to patients.

In particular, it is alleged that he:

• Failed to maintain the standards of practice of the profession;
• Falsified records relating to his practice;
• Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
• Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Eddie Slama, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager, shareholder and/or director at Clairhurst Medical Pharmacy and/or CC Pharmacy, both in Toronto, Ontario, from about January 1, 2016 to May 23, 2019, committed professional misconduct in that he submitted false claims for one or more of certain identified drugs and other products when a different product was actually dispensed to patients.

In particular, it is alleged that he:

• Failed to maintain the standards of practice of the profession;
• Falsified records relating to his practice;
• Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
• Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Eddie Slama, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager, shareholder and/or director at Clairhurst Medical Pharmacy and/or CC Pharmacy, both in Toronto, Ontario, from about June 15, 2017 to August 29, 2019, committed professional misconduct in that he:

• Submitted false claims for one or more of certain identified drugs and other products when a different product was actually dispensed to patients;
• Dispensed free samples of prescription medication, namely compounded pain cream, without valid authorization.

In particular, it is alleged that he:

• Failed to maintain the standards of practice of the profession;
• Falsified records relating to his practice;
• Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
• Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Eddie Slama, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager, shareholder and/or director at Clairhurst Medical Pharmacy and/or CC Pharmacy, both in Toronto, Ontario, from about January 1, 2016 to May 23, 2019, committed professional misconduct in that he submitted claims to [Claims Adjudicator] that included markups on drug products that were excessive and unreasonable.

In particular, it is alleged that he:

• Failed to maintain the standards of practice of the profession;
• Charged a fee that was excessive in relation to the service provided;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Eddie Slama, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager, shareholder and/or director at Clairhurst Medical Pharmacy and/or CC Pharmacy, both in Toronto, Ontario, from about January 9, 2018 to May 29, 2019, committed professional misconduct in that he dispensed and/or billed for certain identified prescription products in absence of a valid prescription.

In particular, it is alleged that he:

• Failed to maintain the standards of practice of the profession;
• Falsified records relating to his practice;
• Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
• Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Eddie Slama, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager, shareholder and/or director at Clairhurst Medical Pharmacy and/or CC Pharmacy, both in Toronto, Ontario, from about December 11, 2019 to about May 5, 2020, committed professional misconduct in that he caused prescriptions to be processed and billed through Main Drug Mart in Thornhill under the auspices of a central fill agreement.

In particular, it is alleged that he:

• Failed to maintain the standards of practice of the profession;
• Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Renee St. Jean, since in or around March 2019, while acting as director, shareholder, owner, Designated Manager, dispensing pharmacist and/or in any other capacity at APlusPharma Ltd., Innomar Strategies Inc. and/or any other corporate entity affiliated with APlusPharma, Innomar Strategies, and/or Innomar Specialty Pharmacy in Barrie, Ontario, committed professional misconduct in that she:

• Practised the profession while in a conflict of interest as defined in Part II of Ontario Regulation 130/17 in relation to the drug product XYREM;
• Participated in an arrangement that constitutes a conflict of interest as defined in Part II of Ontario Regulation 130/17 with respect to the drug product XYREM;
• Entered into an agreement, in relation to the drug product XYREM, that restricted a person’s choice of a pharmacist without the consent of the person;
• Solicited and/or permitted the solicitation of patients to the Pharmacy in relation to the drug product XYREM; and/or,
• Participated in the transition to dispensing XYREM to the Pharmacy exclusively through the Pharmacy in a manner that contravened the principles of Beneficence, Respect for Persons/Justice and Accountability (Fidelity) in the Ontario College of Pharmacists Code of Ethics (the “Code of Ethics”).

In particular, it is alleged that she:

• Failed to maintain a standard of practice of the profession;
• Practised the profession of pharmacy while in a conflict of interest and/or participated in an arrangement that constitutes a conflict of interest;
• Entered into an agreement that restricted one or more persons choice of a pharmacist without the consent of those person(s);
• Solicited and/or permitted the solicitation of one or more patients to the Pharmacy;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional;
• Engaged in conduct that is unbecoming a member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mehari Tekeste, while engaged in the practice of pharmacy as Designated Manager and/or dispensing pharmacist at Ossington Medical Pharmacy in Toronto, Ontario (the “Pharmacy”), and/or as a shareholder and/or director of the corporation that operates the Pharmacy, committed professional misconduct with respect to the following incidents:

• Between about January 1, 2019 and August 26, 2020, he dispensed and/or sold (or permitted, consented to or approved, expressly or impliedly, the dispensing and/or selling of) certain identified prescription drugs without a prescription;
• Between about January and April 2020, he permitted, consented to or approved, expressly or impliedly, a staff member who was not a member of the College dispensing and/or selling a drug and/or supervising the part of the Pharmacy where drugs are kept, when no pharmacist was physically present in the Pharmacy;
• Between about January 1, 2019 and August 26, 2020, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for certain identified drugs and/or products that were not dispensed;
• Between about January 1, 2019 and August 26, 2020, he created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the dispensing of certain identified drugs and/or products that were not dispensed;
• He misappropriated certain identified sample medication from the physician’s office adjacent to the Pharmacy;
• Between about January 1, 2019 and August 26, 2020, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for sample medication that the Pharmacy was not charged for, and in particular, with respect to charges for Synjardy, Xarelto and Invokana;
• He permitted, consented to or approved, expressly or impliedly, a staff member documenting that he had performed clinical verification of certain identified prescriptions, when he had not.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Falsified a record relating to his practice or a person’s health record;
• Submitted an account or charge for services or products that he knew or ought to have known contained a false or misleading statement;
• Charged a fee or amount that was excessive in relation to the service or product provided;
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular:
  • s. 155 of the Drug and Pharmacies Regulation Act;
  • s. 149 of the Drug and Pharmacies Regulation Act and s. 27 of the Regulated Health Professions Act, 1991;
• Contravened a federal, provincial or territorial law or municipal by-law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, and in particular:
  • s. C.01.041 of the Food and Drug Regulations, CRC, c 870, made under the Food and Drugs Act;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Medhat Zekry, while engaged in the practice of pharmacy as Designated Manager and/or dispensing pharmacist at The Hamilton Clinic pharmacy in Hamilton, Ontario (the “Pharmacy”), committed professional misconduct with respect to the following incidents:

• Between about July 18, 2016 and October 26, 2016, he failed to ensure that appropriate policies were in place and/or that Pharmacy staff followed appropriate policies relating to the destruction of drugs and/or the personal health information of patients of the Pharmacy;
• Between about July 18, 2016 and October 26, 2016, he failed to ensure that appropriate policies were in place and/or that Pharmacy staff followed appropriate policies relating to the transfer of custody of narcotic medication for methadone maintenance treatment programs;
• Between about July 18, 2016 and December 2018, he failed to ensure the security and/or destruction of drugs and/or the personal health information of patients of the Pharmacy, with respect to items recovered from [Storage Facility] in [Place], Ontario.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.